Konstantin Bogdanov
- Immunology top 5%
- interferon and immune responses 4
-
- Cell death mechanisms and regulation 5
-
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 7
-
- Acute Lymphoblastic Leukemia research 5
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Virus-based gene therapy research 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- David WallachAndrew KovalenkoSeongmin YoonTae‐Bong KangAkhil RajputJin‐Chul KimSang-Wook YoonSeung‐Hoon Yang
- Journals
- The Journal of Experimental Medicine (1 paper)SHILAP Revista de lepidopterología (2 papers)The Journal of Cell Biology (1 paper)
- Partner nations
- RussiaIsraelUnited States
In The Last Decade
Konstantin Bogdanov
27 papers receiving 886 citations
Peers
Comparison fields: 5 of 80
- Immunology 434
- Molecular Biology 671
- Cancer Research 106
- Hematology 52
- Cell Biology 67
Countries citing papers authored by Konstantin Bogdanov
This map shows the geographic impact of Konstantin Bogdanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin Bogdanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin Bogdanov more than expected).
Fields of papers citing papers by Konstantin Bogdanov
This network shows the impact of papers produced by Konstantin Bogdanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin Bogdanov. The network helps show where Konstantin Bogdanov may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Konstantin Bogdanov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 0 | |
| 8 | 2020 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 287 | |
| 11 | 2016 | 3 | |
| 12 | 2015 | 122 | |
| 13 | 2011 | 8 | |
| 14 | 2011 | 161 | |
| 15 | 2010 | 8 | |
| 16 | 2010 | 1 | |
| 17 | 2009 | 3 | |
| 18 | 2007 | 47 | |
| 19 | 2006 | 4 | |
| 20 | 1997 | 18 |
About Konstantin Bogdanov
Konstantin Bogdanov is a scholar working on Hematology, Genetics and Immunology, having authored 33 papers that have together received 896 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Chronic Myeloid Leukemia Treatments (7 papers), Cell death mechanisms and regulation (5 papers), Acute Lymphoblastic Leukemia research (5 papers), interferon and immune responses (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Virus-based gene therapy research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology (434 citations), Molecular Biology (671 citations) and Cancer Research (106 citations). Konstantin Bogdanov has collaborated with scholars based in Russia, Israel and United States. Frequent co-authors include David Wallach, Andrew Kovalenko, Seongmin Yoon, Tae‐Bong Kang, Akhil Rajput, Jin‐Chul Kim, Sang-Wook Yoon, Seung‐Hoon Yang, Ori Brenner and Michael Kracht. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.